Telemedicine with special focus on allergic diseases and asthma—Status 2022: An EAACI position paper
Allergy: European Journal of Allergy and Clinical Immunology, cilt.79, sa.4, ss.777-792, 2024 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 79 Sayı: 4
- Basım Tarihi: 2024
- Doi Numarası: 10.1111/all.15964
- Dergi Adı: Allergy: European Journal of Allergy and Clinical Immunology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, Food Science & Technology Abstracts, Veterinary Science Database
- Sayfa Sayıları: ss.777-792
- Anahtar Kelimeler: e-health, m-health, telecare, telehealth, telemedicine
- Hacettepe Üniversitesi Adresli: Evet
Özet
Efficacious, effective and efficient communication between healthcare professionals (HCP) and patients is essential to achieve a successful therapeutic alliance. Telemedicine (TM) has been used for decades but during the COVID-19 pandemic its use has become widespread. This position paper aims to describe the terminology and most important forms of TM among HCP and patients and review the existing studies on the uses of TM for asthma and allergy. Besides, the advantages and risks of TM are discussed, concluding that TM application reduces costs and time for both, HCP and patients, but cannot completely replace face-to-face visits for physical examinations and certain tests that are critical in asthma and allergy. From an ethical point of view, it is important to identify those involved in the TM process, ensure confidentiality and use communication channels that fully guarantee the security of the information. Unmet needs and directions for the future regarding implementation, data protection, privacy regulations, methodology and efficacy are described.